# Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis

> **NCT03935295** · PHASE4 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 90 (estimated)

## Conditions studied

- Adolescent Idiopathic Scoliosis

## Interventions

- **DRUG:** AbobotulinumtoxinA
- **DRUG:** Placebos
- **DEVICE:** Custom Thoracolumbosacral Orthosis

## Key facts

- **NCT ID:** NCT03935295
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-09-03
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03935295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03935295, "Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03935295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*